These companies from the NIH SBIR/STTR Program will present on the Innovation Pavilion stage. You can also see these companies exhibit at the Innovation Pavilion.
Epitel is revolutionizing the way we monitor brain health with Epilog, our hardware-enabled data analytics platform that takes medical-grade EEG monitoring out of the hospital and into the home for the first time. Epilog provides long-term brain health monitoring where you are, when you need it. Epilepsy is our initial focus because seizures rarely happen in the hospital; they happen where you are. Epilog is easy to use – this discreet non-invasive wearable is worn behind the ear while at home, while you are asleep, or wherever you go. EEG is sent to your smartphone and relayed to the cloud. It then uses powerful machine learning algorithms to provide personalized analytics and seizure reports built on the largest and fastest-growing proprietary EEG database. The Epilog app gives you a digital seizure report, real-time alerts, and an hourly seizure forecast.
Fibralign Corporation is a Stanford University spin-out biotech company that produces novel therapeutic medical devices to address major unmet medical needs. The Company is in commercial sales in the US with its first product, the BioBridge® Collagen Matrix. BioBridge’s first target is treatment and prevention of Secondary Lymphedema, a global chronic disease that currently has no cure. Clinical benefit has already been demonstrated and a Stanford-led multi-site clinical study is currently underway for breast cancer-related lymphedema (funded by an NCI SBIR bridge grant).
Hemotek Medical Inc.
Hemotek Medical Inc. is dedicated to providing patients with safer hemodialysis. Our patented device will reduce deaths and adverse events from Venous Needle Dislodgement. There are ~ 57M needle-based hemodialysis sessions per year in the US and 250M worldwide. The US market opportunity is $20M per year and $100M worldwide.